ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Myeloma in Detroit, MI

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Plasma Cell Cancer
Lymphoma
Hematologic Cancer
Cancer
Leukemia
Smoldering Multiple Myeloma
Non-Hodgkin Lymphoma

Multiple Myeloma trials near Detroit, MI, USA:

A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma

This research study is studying a combination of study drugs as a possible treatment for relapsed and refractory Multiple Myeloma. ...

Active, not recruiting
Multiple Myeloma
Drug: Dexamethasone
Drug: Elotuzumab

Phase 2

Mass General Brigham
Mass General Brigham

Ann Arbor, Michigan, United States and 5 other locations

This research study is studying a targeted therapy as a possible treatment for multiple myeloma.The names of the study drugs involv...

Enrolling
Multiple Myeloma
Drug: Trametinib
Drug: Dabrafenib

Phase 1

Mass General Brigham
Mass General Brigham

Detroit, Michigan, United States and 1 other location

this study is to determine the maximum-tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of ION251 in patients with relapsed/refractory multiple...

Active, not recruiting
Refractory Multiple Myeloma
Relapsed Multiple Myeloma
Drug: ION251

Phase 1

Ionis Pharmaceuticals
Ionis Pharmaceuticals

Detroit, Michigan, United States of America and 5 other locations

This research study is studying a drug as a possible treatment for Monoclonal Gammopathy of Unknown Significance (MGUS) or Smoldering Multiple...

Active, not recruiting
Smoldering Multiple Myeloma
Monoclonal Gammopathy
Drug: Daratumumab

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Detroit, Michigan, United States and 5 other locations

The purpose of this study is to evaluate the safety and preliminary efficacy of CC-92480 in combination with standard treatments.

Active, not recruiting
Multiple Myeloma
Drug: Isatuximab
Drug: CC-92480

Phase 1, Phase 2

Celgene
Celgene

Detroit, Michigan, United States and 48 other locations

This study will be a multi-center, open-label, Phase 2 study where newly diagnosed Multiple Myeloma requiring systemic chemotherapy...

Active, not recruiting
Multiple Myeloma
Drug: Dexamethasone
Drug: Elotuzumab

Phase 2

The University of Chicago
The University of Chicago

Ann Arbor, Michigan, United States and 2 other locations

The purpose of this research study is to evaluate a treatment regimen called IRD which will be given to participants after their stem cell transplant...

Active, not recruiting
Multiple Myeloma
Biological: Ixazomib
Drug: Dexamethasone

Phase 2

The Washington University
The Washington University

Detroit, Michigan, United States and 9 other locations

versus standard regimens in subjects with relapsed and refractory multiple myeloma (RRMM).The study is anticipated to randomize app...

Active, not recruiting
Multiple Myeloma
Biological: bb2121
Drug: Dexamethasone

Phase 3

Celgene
Celgene

Ann Arbor, Michigan, United States and 59 other locations

progression-free survival (PFS) in participants with newly diagnosed multiple myeloma (a blood cancer of plasma cells) who are not ...

Active, not recruiting
Multiple Myeloma
Drug: Daratumumab SC
Drug: Daratumumab IV

Phase 3

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Detroit, Michigan, United States and 211 other locations

versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in newly diagnosed multiple...

Enrolling
Multiple Myeloma
Drug: Fludarabine
Drug: Daratumumab

Phase 3

Stichting European Myeloma Network

Detroit, Michigan, United States and 126 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems